Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cleveland Research Downgrades Roku to Neutral

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.
byBenzinga Newsdesk
October 26, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Praxis Precision Medicines Provides Update On Advancing Clinical Stage Portfolio; Recently Announced Licensing Partnership With Tenacia Biotechnology To Develop And Commercialize Ulixacaltamide In Greater China With Total Consideration Over $275M

By Benzinga Newsdesk
January 8, 9:25 AM
Positive preliminary analysis of 15 mg cohort in the PRAX-628 study in epilepsy patients with Photo-Paroxysmal Response (PPR) exceeds expectations; topline results expected in 1Q 2024 after completion of 45 mg

IONS

Read More

Allstate Announces July 2023 Catastrophe Losses Of $313M Or $247M, After-Tax And Implemented Rate Increases Of 8.2% Across 12 Locations, Resulting In Total Brand Premium Impact Of 0.9%; July Month Catastrophe Losses Include 18 Events Estimated At $349M

By Happy Mohamed
August 17, 8:17 AM
The Allstate Corporation (NYSE:ALL) today announced estimated catastrophe losses for the month of July of $313 million or $247 million, after-tax. July month catastrophe losses include 18 events estimated

ALL